FDA Import Refusal AEK-3431206-4/11/1 — Crescent Pharma Ltd
The FDA refused shipment AEK-3431206-4/11/1 from Crescent Pharma Ltd (United Kingdom) on Jun 12, 2023. The refused product falls under Drugs and Biologics — METFORMIN HCL (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 12, 2023
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY55 METFORMIN HCL (ANTI-DIABETIC)
- Charges
- 75